Immunomodulatory effect of HLA-G Overexpressed Mesenchymal Stromal Cell in Cell-based Therapy for Myocardial Infarction

preprint OA: closed CC-BY-NC-ND-4.0
📄 Open PDF Full text JSON View at publisher
Full text 2,606 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

Background Our previous study demonstrated that intravenous administration of mesenchymal stromal cells (MSCs) significantly increased local cell engraftment and improved heart function. We sought to investigate whether HLA-G1 overexpressed MSCs could further increase local transplanted cells engraftment and improve heart function.

Methods

and Results Mice were randomized to receive intravenous administration of saline, human umbilical cord blood derived MSCs (hUCB-MSCs) 7 days prior to acute myocardial infarction (AMI), induced by ligation of the left anterior descending coronary artery. Then, intramyocardial transplantation of human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) was performed 30 minutes following AMI. Echocardiographic assessment was performed to assess heart function. In-vivo fluorescent imaging analysis were used to analyze cell engraftment. Flow cytometry of splenic regulatory T cells (Tregs) and natural killer (NK) cells was conducted to evaluate the immunomodulatory effect. Our result showed that systemic intravenous administration of hUCB-MSCs significantly increased systemic Tregs, decreased systemic NK cells, increased cell engraftment of intramyocardial transplanted hiPSC-CMs, culminating in improvement of heart function. Our in-vitro study showed that HLA-G1 overexpressed hUCB-MSCs modulated immune response by decreasing pro-inflammatory cytokines.

Conclusions

Systemic intravenous administration of HLA-G1 overexpressed hUCB-MSCs modulated immune response and enhanced the survival of local transplanted hiPSC-CMs to improve heart function following AMI. Competing Interest Statement The authors have declared no competing interest. Nonstandard Abbreviations and Acronyms - AMI - Acute Myocardial Infarction - CM - Cardiomyocyte - FMO - Fluorescence Minus One - FS - Fractional Shortening - FOV - Field Of View - HF - Heart Failure - HLA - Human Leukocyte Antigen - hiPSC - Human Induced Pluripotent Stem Cell - hUCB - Human Umbilical Cord Blood - IDO - Indoleamine 2, 3-Dioxygenase - IFN - Interferon - IL - Interleukin - LVEDD - left ventricular end-diastolic dimension - LVEF - left ventricular ejection fraction - VESD - left ventricular end-systolic dimension - MHC - Major Histocompatibility Complex - MSC - Mesenchymal Stromal Cell - MI - Myocardial Infarction - NK - Natural Killer - PBS - Phosphate Buffered Saline - SEM - Standard Error of the Mean - SMA TNF - Smooth Muscle Antigen Tumor Necrosis Factor - Treg - Regulatory T cell - TUNEL - TdT-mediated dUTP Nick-End Labeling - vWF - Von Willebrand Factor

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-23T02:00:01.238055+00:00
License: CC-BY-NC-ND-4.0